Skip to main content

Animations

MJFF Publications

7331 - 7340 of 8808 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2018
  • 2020
  • 2019
  • 2020
  • 2025
  • 2021
  • 2017
  • 2016
  • Summary Details
    RESTRICTED
    Title: Placebo Effects in the Treatment of Depression—Implications for the Psychedelic Renaissance
    Journal Name: Neurologic Clinics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ncl.2025.08.009
    Citation Count: 0
  • Summary Details
    OPEN
    Title: AI-Validated Brain Targeted mRNA Lipid Nanoparticles with Neuronal Tropism
    Journal Name: ACS Nano
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acsnano.4c15013
    Citation Count: 2
  • Summary Details
    OPEN
    Title: α‐Synuclein stimulation of monoamine oxidase‐B and legumain protease mediates the pathology of Parkinson's disease
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.15252/embj.201798878
    Citation Count: 84
  • Summary Details
    OPEN
    Title: Distinct Roles for RAB10 and RAB29 in Pathogenic LRRK2-Mediated Endolysosomal Trafficking Alterations
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells9071719
    Citation Count: 30
  • Summary Details
    OPEN
    Title: PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating Rab proteins
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.50416
    Citation Count: 121
  • Summary Details
    OPEN
    Title: Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synuclein
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.aba1193
    Citation Count: 58
  • Summary Details
    OPEN
    Title: Inhibitory basal ganglia nuclei differentially innervate pedunculopontine nucleus subpopulations and evoke differential motor and valence behaviors
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.102308.3
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Comprehensive subtyping of Parkinson’s disease patients with similarity fusion: a case study with BioFIND data
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00228-0
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Functional connectivity disruptions correlate with cognitive phenotypes in Parkinson's disease
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2017.03.002
    Citation Count: 100
  • Summary Details
    OPEN
    Title: Dual Tasking for the Differentiation between Depression and Mild Cognitive Impairment
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2016.00235
    Citation Count: 20
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.